AMA CPT® Assistant - 2022 Issue 9 (September)
New COVID-19 Vaccine Codes: September Update (September Special Update 2022)
September Special Update 2022 page 1 New COVID-19 Vaccine Codes: September Update The Current Procedural Terminology (CPT®) Editorial Panel (the Panel) has approved two vaccine product codes (91312, 91315) and two vaccine administration codes (0124A, 0154A) for the new Pfizer bivalent booster vaccine to address severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) for patients aged 12 years and older and in pediatric patients aged 5 through 11 years. In addition, the Panel has approved two vaccine product codes (91313, 91314) and two vaccine administration codes (0134A, 0144A) for the new Moderna bivalent booster vaccine...
Subscribe or sign in to view the full article.
Article Overview
This CPT® Assistant update explains newly approved COVID-19 vaccine product and administration coding for Pfizer and Moderna bivalent booster vaccines. It is intended for coders, billers, and clinical documentation staff who need to track current CPT guidance, Appendix Q updates, age-based vaccine code pairings, and related immunization reporting context. The article also includes clinical examples and procedural descriptions to illustrate the new code structure in general terms.
Why This Topic Matters
It helps readers stay current with CPT vaccine code changes and understand how the September 2022 update fits into the broader COVID-19 immunization coding guidance.
Article Sections
-
September Special Update 2022 page 1
Introductory update describing newly approved COVID-19 vaccine product and administration coding and the organizations involved in issuing the guidance.
-
Immunization Administration for Vaccines/Toxoids
CPT vaccine administration content organized by the new COVID-19 booster administration codes and their general reporting context.
-
Vaccines, Toxoids
CPT vaccine product content organized by the corresponding COVID-19 vaccine product codes and related reporting context.
-
Table 1 Excerpt from Appendix Q: New Pfizer and Moderna COVID-19 Vaccine Product and Administration Codes
A table-style summary of the new vaccine product and administration code relationships along with patient age group information.
-
Clinical Examples and Description of Procedure
Illustrative clinical scenarios and procedural narrative examples showing how the new COVID-19 vaccine coding guidance is presented in practice.
What You Will Learn
- Which COVID-19 vaccine coding updates were added in the September 2022 CPT Assistant special update
- How the article organizes vaccine product and administration code information
- What Appendix Q contributes to COVID-19 vaccine code guidance
- How the article frames age-based vaccine coding context
- What types of clinical examples are included to support the update
Who Should Read This
- Medical coders
- Billing staff
- Clinical documentation specialists
- Practice managers
- Immunization reporting staff
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com